FILE PHOTO: Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey (Reuters) - The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in ...
The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drug Januvia, were contaminated with a possible carcinogen. Aug 9 (Reuters) - The U ...
Aug 9 (Reuters) - The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's MRK.N diabetes drug Januvia, were contaminated with a possible carcinogen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback